These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 33044406
21. Differential diagnostic value of single-photon emission computed tomography/spiral computed tomography with Tc-99m-methylene diphosphonate in patients with spinal lesions. Zhang Y, Shi H, Gu Y, Xiu Y, Li B, Zhu W, Chen S, Yu H. Nucl Med Commun; 2011 Dec; 32(12):1194-200. PubMed ID: 21934544 [Abstract] [Full Text] [Related]
22. The value of quantitative analysis in 18F-NaF PET/CT. Lapa P, Marques M, Costa G, Lima JP. Rev Esp Med Nucl Imagen Mol; 2017 Dec; 36(2):78-84. PubMed ID: 27793635 [Abstract] [Full Text] [Related]
23. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP. Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W. Hell J Nucl Med; 2017 Dec; 20(3):237-240. PubMed ID: 29177262 [Abstract] [Full Text] [Related]
24. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history. Zhang Y, Shi H, Li B, Xiu Y, Cai L, Gu Y, Chen S. Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199 [Abstract] [Full Text] [Related]
25. Diagnosis of Insufficiency Fracture After Radiotherapy in Patients With Cervical Cancer: Contribution of Technetium Tc 99m-Labeled Methylene Diphosphonate Single-Photon Emission Computed Tomography/Computed Tomography. Zhang L, He Q, Jiang M, Zhang B, Zhong X, Zhang R. Int J Gynecol Cancer; 2018 Sep; 28(7):1369-1376. PubMed ID: 30095704 [Abstract] [Full Text] [Related]
26. Quantitative [99mTc]Tc-MDP SPECT/CT correlated with [18F]NaF PET/CT for bone metastases in patients with prostate cancer. Tanaka K, Norikane T, Mitamura K, Yamamoto Y, Maeda Y, Fujimoto K, Takami Y, Ishimura M, Arai-Okuda H, Tohi Y, Kudomi N, Sugimoto M, Nishiyama Y. EJNMMI Phys; 2022 Dec 05; 9(1):83. PubMed ID: 36469149 [Abstract] [Full Text] [Related]
27. Quantitative assessment of 99mTc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial results in a single-center retrospective study. Oya T, Ichikawa Y, Nakamura S, Tomita Y, Sasaki T, Inoue T, Sakuma H. Ann Nucl Med; 2023 Jun 05; 37(6):360-370. PubMed ID: 36947324 [Abstract] [Full Text] [Related]
28. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography. Bando R, Otsuka H, Otani T, Matsuda N, Azane S, Kunikane Y, Otomi Y, Sako W, Izumi Y, Harada M. Ann Nucl Med; 2021 Apr 05; 35(4):504-513. PubMed ID: 33630226 [Abstract] [Full Text] [Related]
29. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients. Umeda T, Koizumi M, Fukai S, Miyaji N, Motegi K, Nakazawa S, Takiguchi T. Ann Nucl Med; 2018 Feb 05; 32(2):105-113. PubMed ID: 29243019 [Abstract] [Full Text] [Related]
30. Inter- and intraobserver agreement in standard and ultra-fast single-photon emission computed tomography/computed tomography for the assessment of bone metastases. Zacho HD, Aleksyniene R, Ejlersen JA, Fledelius J, Petersen LJ. Nucl Med Commun; 2020 Oct 05; 41(10):1005-1009. PubMed ID: 32694282 [Abstract] [Full Text] [Related]
31. Comparison of hybrid 68Ga-PSMA-PET/CT and 99mTc-DPD-SPECT/CT for the detection of bone metastases in prostate cancer patients: Additional value of morphologic information from low dose CT. Janssen JC, Meißner S, Woythal N, Prasad V, Brenner W, Diederichs G, Hamm B, Makowski MR. Eur Radiol; 2018 Feb 05; 28(2):610-619. PubMed ID: 28779400 [Abstract] [Full Text] [Related]
32. Maximum standardized uptake value of foot SPECT/CT using Tc-99m HDP in patients with accessory navicular bone as a predictor of surgical treatment. Bae S, Kang Y, Song YS, Lee WW, K-SPECT Group. Medicine (Baltimore); 2019 Jan 05; 98(2):e14022. PubMed ID: 30633193 [Abstract] [Full Text] [Related]
33. Quantification evaluation of 99mTc-MDP concentration in the lumbar spine with SPECT/CT: compare with bone mineral density. Huang K, Feng Y, Liu D, Liang W, Li L. Ann Nucl Med; 2020 Feb 05; 34(2):136-143. PubMed ID: 31768820 [Abstract] [Full Text] [Related]
34. Clinical value of the threshold derived from bone single-photon emission computed tomography/computed tomography in differentiating sternoclavicular arthritis. Tsuchitani T, Kitajima K, Azuma N, Tamura M, Takahashi Y, Kotoura N. Hell J Nucl Med; 2022 Feb 05; 25(1):32-37. PubMed ID: 35388802 [Abstract] [Full Text] [Related]
35. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer. Abikhzer G, Srour S, Fried G, Drumea K, Kozlener E, Frenkel A, Israel O, Fogelman I, Kagna O. Nucl Med Commun; 2016 Nov 05; 37(11):1160-8. PubMed ID: 27536906 [Abstract] [Full Text] [Related]
36. Comparison of [68Ga]Ga-PSMA-11 PET/CT with [18F]NaF PET/CT in the evaluation of bone metastases in metastatic prostate cancer patients prior to radionuclide therapy. Uprimny C, Svirydenka A, Fritz J, Kroiss AS, Nilica B, Decristoforo C, Haubner R, von Guggenberg E, Buxbaum S, Horninger W, Virgolini IJ. Eur J Nucl Med Mol Imaging; 2018 Oct 05; 45(11):1873-1883. PubMed ID: 29766246 [Abstract] [Full Text] [Related]
37. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X. Zhonghua Zhong Liu Za Zhi; 2012 May 05; 34(5):364-8. PubMed ID: 22883458 [Abstract] [Full Text] [Related]
38. PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients. Lim CH, Ahn TR, Moon SH, Cho YS, Choi JY, Kim BT, Lee KH. Eur Radiol; 2019 Apr 05; 29(4):1903-1911. PubMed ID: 30315418 [Abstract] [Full Text] [Related]
39. Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy. Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS. J Comput Assist Tomogr; 2007 Apr 05; 31(5):812-9. PubMed ID: 17895798 [Abstract] [Full Text] [Related]
40. The Prognostic Value of Quantitative Bone SPECT/CT Before 223Ra Treatment in Metastatic Castration-Resistant Prostate Cancer. Dittmann H, Kaltenbach S, Weissinger M, Fiz F, Martus P, Pritzkow M, Kupferschlaeger J, la Fougère C. J Nucl Med; 2021 Jan 05; 62(1):48-54. PubMed ID: 32444369 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]